Product Information
VARENICLINE STARTING MONTH BOX is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3972 per EA under NDC 33342057749. Its NADAC has been published 52 times since Oct 8, 2025.
FDA first approved this application on Dec 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342057749
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA215048FDA Approved
12/9/2024
TE Code
AB
On Market Since
12/10/2024
Price Statistics
The NADAC for VARENICLINE STARTING MONTH BOX has been published 52 times since Oct 8, 2025, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3972 per EA |
|---|---|
| All-time high | $0.5229 (May 13, 2026) |
| All-time low | $0.3972 (Sep 23, 2026) |
| 52-week high | $0.5229 |
| 52-week low | $0.3972 |
| Median price | $0.5000 |
| Average price | $0.4891 |
| Largest weekly change | -12.8% (Aug 19, 2026) |
| Weeks tracked | 52 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Varenicline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARENICLINE STARTING MONTH BOX?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE STARTING MONTH BOX, manufactured by Macleods Pharmaceuticals Limited, is $0.3972 per EA (NDC 33342057749), effective Sep 30, 2026.
How has the price of VARENICLINE STARTING MONTH BOX changed over time?
Over the history we have for it, the NADAC for VARENICLINE STARTING MONTH BOX has declined 18.9%. It has been tracked across 52 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for VARENICLINE STARTING MONTH BOX?
Since Oct 8, 2025, the NADAC for VARENICLINE STARTING MONTH BOX has ranged from a low of $0.3972 (Sep 23, 2026) to a high of $0.5229 (May 13, 2026), with a median of $0.5000 per EA.
Are there cheaper alternatives to VARENICLINE STARTING MONTH BOX?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VARENICLINE STARTING MONTH BOX in a comparable dosage form, but none are currently priced below it.
Who manufactures VARENICLINE STARTING MONTH BOX?
VARENICLINE STARTING MONTH BOX (NDC 33342057749) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.